SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-034865
Filing Date
2024-03-21
Accepted
2024-03-21 17:10:06
Documents
7
Effectiveness Date
2024-03-21

Document Format Files

Seq Description Document Type Size
1 S-8 dnth-form_s-8-2024.htm S-8 155515
2 EX-5.1 dnth-ex5_1.htm EX-5.1 19912
3 EX-23.1 dnth-ex23_1.htm EX-23.1 2307
4 EX-99.2 dnth-ex99_2.htm EX-99.2 122991
5 EX-99.3 dnth-ex99_3.htm EX-99.3 60556
6 EX-FILING FEES dnth-exfiling_fees.htm EX-FILING FEES 43156
7 GRAPHIC img173831800_0.jpg GRAPHIC 8529
  Complete submission text file 0000950170-24-034865.txt   417511
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278151 | Film No.: 24772253
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)